N-Methylcarfentanil
N-Methylcarfentanil is a synthetic opioid and an analog of carfentanil, itself a highly potent analog of fentanyl. N-Methylcarfentanil is distinguished from carfentanil by the substitution of a methyl group on the nitrogen atom of the piperidine ring. This modification results in a compound that is a potent agonist of the mu-opioid receptor, with pharmacological effects similar to those of other potent opioids, including analgesia and sedation, but with a potentially higher risk of overdose and adverse effects due to its extreme potency.
Chemistry[edit | edit source]
N-Methylcarfentanil belongs to the 4-anilidopiperidine class of synthetic opioids. Its chemical structure is closely related to that of carfentanil, differing only by the addition of a methyl group on the nitrogen atom of the piperidine ring. This minor structural modification significantly impacts its pharmacological profile, making it one of the most potent opioids known.
Pharmacology[edit | edit source]
The primary mechanism of action of N-Methylcarfentanil is its agonism at the mu-opioid receptor, which is responsible for its potent analgesic effects. Like other opioids, it produces analgesia by mimicking the action of endogenous opioid peptides at mu-opioid receptors in the brain and spinal cord, inhibiting the transmission of pain signals. However, due to its high affinity for these receptors, N-Methylcarfentanil is capable of producing profound analgesia at extremely low doses.
Adverse Effects[edit | edit source]
The adverse effects of N-Methylcarfentanil are similar to those of other potent opioids and include respiratory depression, nausea, vomiting, sedation, and constipation. Due to its extreme potency, there is a high risk of overdose, which can lead to fatal respiratory depression. The use of N-Methylcarfentanil outside of a controlled medical setting is extremely dangerous and can result in accidental exposures with severe or fatal outcomes.
Legal Status[edit | edit source]
N-Methylcarfentanil is a controlled substance in many countries due to its potential for abuse, dependence, and harm. Its legal status varies by jurisdiction, but it is often classified alongside other highly potent synthetic opioids with strict regulations governing its manufacture, distribution, and use.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD